about
Associations between muscle strength, spirometric pulmonary function and mobility in healthy older adultsNMR based biomarkers to study age-related changes in the human quadriceps.Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical TrialsGait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.Assessment of maximal handgrip strength: how many attempts are needed?Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.New insights on contraction efficiency in patients with Duchenne muscular dystrophy.Stature is an essential predictor of muscle strength in children.Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.Ankle dorsi- and plantar-flexion torques measured by dynamometry in healthy subjects from 5 to 80 years.Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study.Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial.Wrist flexion and extension torques measured by highly sensitive dynamometer in healthy subjects from 5 to 80 years.Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trialGrip strength measured by high precision dynamometry in healthy subjects from 5 to 80 yearsNMR imaging estimates of muscle volume and intramuscular fat infiltration in the thigh: variations with muscle, gender, and age.A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment.Clinical applications of surface electromyography in neuromuscular disorders.Natural history of LGMD2A for delineating outcome measures in clinical trialsTriheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiencySerum albumin and muscle measures in a cohort of healthy young and old participants.Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.Extensive morphological and immunohistochemical characterization in myotubular myopathy.Association between osteocalcin and cognitive performance in healthy older adults.Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype.Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study.Measuring Habitual Physical Activity in Neuromuscular Disorders: A Systematic Review.Dehydroepiandrosterone for myotonic dystrophy type 1.Two new cases of mitochondrial myopathy with exercise intolerance, hyperlactatemia and cardiomyopathy, caused by recessive SLC25A4 mutations.Cross-sectional retrospective study of muscle function in patients with glycogen storage disease type III.Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials.Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy.Manual segmentation of individual muscles of the quadriceps femoris using MRI: a reappraisal.Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.Quantitative myotonia assessment using force relaxation curve modelling.Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy.Coupling between skeletal muscle fiber size and capillarization is maintained during healthy agingA non-ischemic forearm exercise test for the screening of patients with exercise intolerance.
P50
Q28393400-A5712045-0FFE-44EA-991E-785B6669FACDQ30977498-3A91E2DE-481C-44AE-869E-D721B30402AEQ31131975-997395A6-AC05-424C-9CEE-634762D97D65Q33555880-F7EAFB49-6B9E-4FCC-93C7-F2213D231991Q33813597-EC55CAD3-ACD7-4735-9922-568A421B14C9Q34041966-23054A27-9C45-4F9B-B4AA-8FB42C2EE8B3Q34146934-29B2E626-C687-4113-870B-561BE26148AEQ34417938-380A9C13-792F-4C22-8AC1-B16DC38F124BQ34499428-6658C47D-FA89-4283-9A56-E5AA90EDEF61Q34632823-19C64984-F64E-416E-A360-A7E6FC12046BQ34963315-EA023FB9-C7BC-4921-A0F4-DCA41AF6B06CQ35038830-1D669ABE-507A-41A3-9511-C522E3D5E34AQ35067323-46BC146D-4A5A-4224-B7A5-50A9D09AD018Q35364301-833FC675-4432-467C-AE83-24E16D249066Q35657478-5E14168A-D76E-49DC-A82E-7FD571235C19Q35685709-EFC1B2A2-9D47-4989-8035-1CB7B60AE811Q36043426-D650B6EE-A616-43C5-91A9-A1CD28284AB9Q36222350-A31D4ABE-1AAF-46AB-A25F-0A8A4418D959Q36759458-325B02AE-C1E4-4909-9B20-2DF3F4812E2CQ36859501-0CF2AC3E-454D-4B4B-BB68-4A9131999175Q37219275-E2CB97A1-BEC5-4600-9328-20D1CB20DD23Q37394520-D5D96279-7228-4DAF-9050-097FDD88436FQ37407306-22820CCE-5D65-4314-82C9-5C1D563A1922Q37409308-8BF79541-1049-42D0-8563-06A8856FCAAEQ37589614-7BC73DA6-2722-4555-AC02-B97D738B58C8Q37610370-9FDB30F6-DC69-462C-858C-185665B91234Q37693358-8ECB6B2C-E575-41CF-8210-8E2AF3F53B41Q38388268-76228938-19EF-4642-B595-B7AEE2F9CE9BQ38639937-CB4E749C-B79B-4685-A07A-5F15E21C9956Q38837653-075AC4D1-99F7-49B4-9BD4-7EBB1AD1E432Q39187203-79F28889-E136-4DC5-A3E1-01E1373639EAQ39213123-3B901F87-2791-46A8-AA9A-5B06278F4427Q39234391-41781084-6B21-47E0-BB67-C38E574033AEQ39596023-35344034-282E-4C0B-BAD5-0BAB472E88B1Q39890598-E78237C7-5EFD-4CCD-AF3C-EBF49B49AC08Q40109350-63E20A6B-30D2-4C45-A312-9E73A823DE61Q40318313-DFC2C9AA-E3E8-46DB-A8B1-639C01CE7AB5Q40459778-C70577A9-EA81-445C-9CD4-C7A691CD7728Q41485445-ABCEF357-EF1F-490A-BDBA-A45D31A08CC4Q43653462-10FCD5D1-E825-41D4-9A34-B6FC91BC0E0D
P50
description
researcher ORCID ID = 0000-0003-0045-7505
@en
wetenschapper
@nl
name
Jean-Yves Hogrel
@ast
Jean-Yves Hogrel
@en
Jean-Yves Hogrel
@es
Jean-Yves Hogrel
@nl
type
label
Jean-Yves Hogrel
@ast
Jean-Yves Hogrel
@en
Jean-Yves Hogrel
@es
Jean-Yves Hogrel
@nl
prefLabel
Jean-Yves Hogrel
@ast
Jean-Yves Hogrel
@en
Jean-Yves Hogrel
@es
Jean-Yves Hogrel
@nl
P106
P1153
6603547808
P2456
P31
P496
0000-0003-0045-7505